Cargando…

Click-to-Chelate: Development of Technetium and Rhenium-Tricarbonyl Labeled Radiopharmaceuticals

The Click-to-Chelate approach is a highly efficient strategy for the radiolabeling of molecules of medicinal interest with technetium and rhenium-tricarbonyl cores. Reaction of azide-functionalized molecules with alkyne prochelators by the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC; click rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kluba, Christiane A., Mindt, Thomas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270534/ https://www.ncbi.nlm.nih.gov/pubmed/23481882 http://dx.doi.org/10.3390/molecules18033206

Ejemplares similares

New leads for fragment-based design of rhenium/technetium radiopharmaceutical agents
por: Brink, Alice, et al.
Publicado: (2017)

Synthesis of multidentate ligands with amido or amino donor groups for the preparation of rhenium and technetium radiopharmaceuticals
por: Al-Nuzal, S. M. D., et al.
Publicado: (2012)

Rhenium Tricarbonyl Complexes of Azodicarboxylate Ligands
por: Jordan, Rose, et al.
Publicado: (2022)

Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry
por: Kleynhans, Janke, et al.
Publicado: (2023)

Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands
por: Martini, Petra, et al.
Publicado: (2018)

Lattice Dynamics of the Rhenium and Technetium Dichalcogenides
por: Wolverson, Daniel, et al.
Publicado: (2016)

Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of (99m)Tc-Tricarbonyl-Based Radiopharmaceuticals
por: Giammei, Carolina, et al.
Publicado: (2020)

Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy
por: Liew, Hui Shan, et al.
Publicado: (2020)

Optimising the radiolabelling properties of technetium tricarbonyl and His-tagged proteins
por: Badar, Adam, et al.
Publicado: (2014)

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
por: Lepareur, Nicolas, et al.
Publicado: (2019)

Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals
por: Davey, Patrick R. W. J., et al.
Publicado: (2022)

An Anticancer Rhenium Tricarbonyl Targets Fe−S Cluster Biogenesis in Ovarian Cancer Cells
por: Neuditschko, Benjamin, et al.
Publicado: (2022)

μ-Hydroxido-bis[(2,2′-bipyridine)tricarbonylrhenium(I)] perrhenate
por: Ruth, Kai, et al.
Publicado: (2008)

Substitution reactivity and structural variability induced by tryptamine on the biomimetic rhenium tricarbonyl complex
por: Jacobs, Frederick J. F., et al.
Publicado: (2021)

Rhenium and Technetium-oxo Complexes with Thioamide Derivatives of Pyridylhydrazine Bifunctional Chelators Conjugated to the Tumour Targeting Peptides Octreotate and Cyclic-RGDfK
por: North, Andrea J., et al.
Publicado: (2017)

Technetium-99m Tricarbonyl Labeled a Broad-spectrum Quinolone as a Specific Imaging Agent in Infection Diseases
por: Khoramrouz, Seyed Javad, et al.
Publicado: (2017)

Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs
por: Sharma S., Ajay, et al.
Publicado: (2022)

Rhenium(I) Tricarbonyl Complexes of 1,10-Phenanthroline Derivatives with Unexpectedly High Cytotoxicity
por: Enslin, Lucy E., et al.
Publicado: (2023)

Tetra-μ(3)-hydroxido-tetrakis[tricarbonylrhenium(I)] pyridine tetrasolvate
por: Schutte, M., et al.
Publicado: (2012)

Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities
por: Boschi, Alessandra, et al.
Publicado: (2022)

fac-Bis(acetonitrile-κN)tricarbonyl(trifluoroacetato-κO)rhenium(I)
por: Kia, Reza, et al.
Publicado: (2008)

New Bioconjugated Technetium and Rhenium Folates Synthesized by Transmetallation Reaction with Zinc Derivatives
por: Borràs, Jordi, et al.
Publicado: (2021)

Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures
por: Maioli, Claudio, et al.
Publicado: (2017)

Enhanced Efficacy of Radiopharmaceuticals When Using Technetium-99m-Labeled Liposomal Agents: Synthesis and Pharmacokinetic Properties
por: Alkandari, Anfal M., et al.
Publicado: (2022)

Synthesis and Characterization of Novel [2 + 1] Tricarbonyl Rhenium Complexes with the Hydrophilic Phosphine Ligands PTA and CAP
por: Roupa, Ioanna, et al.
Publicado: (2022)

Antimicrobial Activity of Rhenium Di- and Tricarbonyl Diimine Complexes: Insights on Membrane-Bound S. aureus Protein Binding
por: Schindler, Kevin, et al.
Publicado: (2022)

AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications
por: Fersing, Cyril, et al.
Publicado: (2022)

Recent Advances in Bioorthogonal Click Chemistry for Efficient Synthesis of Radiotracers and Radiopharmaceuticals
por: Mushtaq, Sajid, et al.
Publicado: (2019)

Direct Technetium radiopharmaceuticals production using a 30MeV Cyclotron
por: Jalilian, AR., et al.
Publicado: (2011)

Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes
por: Shimizu, Yoichi, et al.
Publicado: (2021)

3p-C-NETA: A versatile and effective chelator for development of Al(18)F-labeled and therapeutic radiopharmaceuticals
por: Ahenkorah, Stephen, et al.
Publicado: (2022)

Evaluation of Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivatives as Potential EGFR Agents
por: Makrypidi, Konstantina, et al.
Publicado: (2023)

Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013)

Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach
por: Lahnif, Hanane, et al.
Publicado: (2021)

Unexpected Redox Chemistry of P∩N- and As∩N-Rhenium(I) Tricarbonyl Complexes in the Presence of CO(2) Acting as an Acid
por: Ertl, Martin, et al.
Publicado: (2023)

Synthesis, structural characterization and study of antioxidant and anti-PrP(Sc) properties of flavonoids and their rhenium(I)–tricarbonyl complexes
por: Glykofridi, Pigi, et al.
Publicado: (2023)

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
por: Cusnir, Ruslan, et al.
Publicado: (2017)

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
por: Holik, Holis Abdul, et al.
Publicado: (2022)

Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate
por: Gundogdu, Evren, et al.
Publicado: (2020)

The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist
por: Abiraj, Keelara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4jih89jelbsgf5of1v2tg4ko6l